Fujian Wanchen Biotechnology Group Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Part of MojoOne Strategy

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Fujian Wanchen Biotechnology Group Co., Ltd.

Why is Fujian Wanchen Biotechnology Group Co., Ltd. ?

With a growth in Net Profit of 193.12%, the company declared Outstanding results in Sep 25

The company has declared positive results for the last 4 consecutive quarters
OPERATING CASH FLOW(Y) Highest at CNY 2,258.65 MM
INTEREST COVERAGE RATIO(Q) Highest at 7,500.77
ROCE(HY) Highest at 72.05%

With ROE of 81.98%, it has a expensive valuation with a 20.24 Price to Book Value

Over the past year, while the stock has generated a return of 48.97%, its profits have risen by 2287% ; the PEG ratio of the company is 0

Market Beating performance in long term as well as near term

Along with generating 48.97% returns in the last 1 year, the stock has outperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to Fujian Wanchen Biotechnology Group Co., Ltd. should be less than 10%
Overall Portfolio exposure to Other Agricultural Products should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Other Agricultural Products)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Fujian Wanchen Biotechnology Group Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Fujian Wanchen Biotechnology Group Co., Ltd.

48.97%

16.50

53.05%

China Shanghai Composite

26.42%

2.04

12.97%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

240.59%

EBIT Growth (5y)

267.09%

EBIT to Interest (avg)

9.86

Debt to EBITDA (avg)

0.40

Net Debt to Equity (avg)

-1.12

Sales to Capital Employed (avg)

9.53

Tax Ratio

36.09%

Dividend Payout Ratio

35.00%

Pledged Shares

Institutional Holding

ROCE (avg)

8.42%

ROE (avg)

20.88%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

20.24

EV to EBIT

16.33

EV to EBITDA

14.14

EV to Capital Employed

-88.14

EV to Sales

0.70

PEG Ratio

0.02

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

81.98%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Dow Theory

Mildly Bearish

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

51What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 2,258.65 MM

INTEREST COVERAGE RATIO(Q)

Highest at 7,500.77

ROCE(HY)

Highest at 72.05%

DEBT-EQUITY RATIO (HY)

Lowest at -134.75 %

DEBTORS TURNOVER RATIO(HY)

Highest at 606.19 times

OPERATING PROFIT(Q)

Highest at CNY 895.55 MM

OPERATING PROFIT MARGIN(Q)

Highest at 6.41 %

PRE-TAX PROFIT(Q)

Highest at CNY 953.28 MM

NET PROFIT(Q)

Highest at CNY 383.41 MM

RAW MATERIAL COST(Y)

Fallen by -26.45% (YoY

CASH AND EQV(HY)

Highest at CNY 7,628.93 MM

NET SALES(Q)

Highest at CNY 13,979.75 MM

EPS(Q)

Highest at CNY 1.9

-3What is not working for the Company

INTEREST(9M)

At CNY 41.7 MM has Grown at 13.22%

Here's what is working for Fujian Wanchen Biotechnology Group Co., Ltd.

Interest Coverage Ratio

Highest at 7,500.77 and Grown

In each period in the last five periods

MOJO Watch

The company's ability to manage interest payments is improving

Operating Profit to Interest

Pre-Tax Profit

At CNY 953.28 MM has Grown at 209.17%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 383.41 MM has Grown at 361.22%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Operating Cash Flow

Highest at CNY 2,258.65 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Sales

At CNY 13,979.75 MM has Grown at 44.15%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very positive

Net Sales (CNY MM)

Operating Profit

Highest at CNY 895.55 MM and Grown

In each period in the last five periods

MOJO Watch

Near term Operating Profit trend is quite positive

Operating Profit (CNY MM)

Operating Profit Margin

Highest at 6.41 % and Grown

In each period in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit

Highest at CNY 953.28 MM and Grown

In each period in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 383.41 MM and Grown

In each period in the last five periods

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Debt-Equity Ratio

Lowest at -134.75 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Debtors Turnover Ratio

Highest at 606.19 times and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Net Sales

Highest at CNY 13,979.75 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

EPS

Highest at CNY 1.9

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Cash and Eqv

Highest at CNY 7,628.93 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost

Fallen by -26.45% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Fujian Wanchen Biotechnology Group Co., Ltd.

Interest

At CNY 41.7 MM has Grown at 13.22%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)